Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun 6;84(11):2070-2086.e20.
doi: 10.1016/j.molcel.2024.04.007. Epub 2024 May 3.

The MYCN oncoprotein is an RNA-binding accessory factor of the nuclear exosome targeting complex

Affiliations
Free article

The MYCN oncoprotein is an RNA-binding accessory factor of the nuclear exosome targeting complex

Dimitrios Papadopoulos et al. Mol Cell. .
Free article

Abstract

The MYCN oncoprotein binds active promoters in a heterodimer with its partner protein MAX. MYCN also interacts with the nuclear exosome, a 3'-5' exoribonuclease complex, suggesting a function in RNA metabolism. Here, we show that MYCN forms stable high-molecular-weight complexes with the exosome and multiple RNA-binding proteins. MYCN binds RNA in vitro and in cells via a conserved sequence termed MYCBoxI. In cells, MYCN associates with thousands of intronic transcripts together with the ZCCHC8 subunit of the nuclear exosome targeting complex and enhances their processing. Perturbing exosome function results in global re-localization of MYCN from promoters to intronic RNAs. On chromatin, MYCN is then replaced by the MNT(MXD6) repressor protein, inhibiting MYCN-dependent transcription. RNA-binding-deficient alleles show that RNA-binding limits MYCN's ability to activate cell growth-related genes but is required for MYCN's ability to promote progression through S phase and enhance the stress resilience of neuroblastoma cells.

Keywords: MAX; MNT; MXD; MYC; MYCN; NEXT; ZCCHC8; exosome; neuroblastoma.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests M.E. is a founder of and shareholder of Tucana Biosciences.

MeSH terms